SCANGOS GEORGE A

Chief Executive Officer

C-suiteM

US·SEC (Form 4)

Vir Biotechnology, Inc.Agilent Technologies, INC.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€281,377

▼ Sales (1 ops.)

Discover the full record of transactions filed by SCANGOS GEORGE A, Chief Executive Officer. Officer active across 2 companies, notably Vir Biotechnology, Inc.. In total, 3 filings have been recorded. Total volume traded: €281k. The latest transaction was filed on 10 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.

Declarations3 total

Executives◆GrantVVir Biotechnology, Inc.29SEC

S

SCANGOS GEORGE APresident and CEO

0111,000 shares0

Common Stock

SEC:0001209191-22-023524:0·10 Mar 2022

SEC ↗

Executives◆GrantAAgilent Technologies, INC.22SEC

S

SCANGOS GEORGE ADirector

€221,5791,785 shares@ €124.13410.0007% mcap100.0% of flow

Common Stock

SEC:0001127602-22-010055:0·17 Mar 2022

SEC ↗

Executives▼SaleVVir Biotechnology, Inc.◆Signal · 59SEC

S

SCANGOS GEORGE APresident and CEO

€281,37710,024 shares@ €28.07040.033% mcap100.0% of flow

Common Stock

SEC:0001209191-22-011756:0·17 Feb 2022

SEC ↗

3 of 3 declarations

About SCANGOS GEORGE A

George A. Scangos is the President and CEO of Vir Biotechnology, Inc. and Agilent Technologies, Inc. He leads corporate strategies and growth initiatives, focusing on innovation in the biotechnology sector. His experience is a significant asset to both companies.